Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abeona Therapeutics

6.74
-0.1300-1.89%
Volume:1.21M
Turnover:8.30M
Market Cap:327.12M
PE:-4.34
High:7.08
Open:6.96
Low:6.62
Close:6.87
Loading ...

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
03 Feb

BRIEF-Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
31 Dec 2024

Abeona Therapeutics announces employee inducement grants

TIPRANKS
·
31 Dec 2024

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
31 Dec 2024

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
31 Dec 2024

Owning 43% shares,institutional owners seem interested in Abeona Therapeutics Inc. (NASDAQ:ABEO),

Simply Wall St.
·
28 Dec 2024

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
02 Dec 2024

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
02 Dec 2024

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ACCESSWIRE
·
27 Nov 2024

Abeona Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Nov 2024

Positive Outlook for Abeona Therapeutics: FDA Acceptance and Strategic Initiatives Reinforce Buy Rating

TIPRANKS
·
25 Nov 2024

ABEO: FDA Accepts BLA Re-Submission for Pz-cel; PDUFA Date of April 29, 2025; Raising Valuation to $9.50…

Zacks Small Cap Research
·
19 Nov 2024

Abeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
15 Nov 2024

Abeona Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

Abeona Therapeutics: Q3 Earnings Snapshot

Associated Press Finance
·
14 Nov 2024

Abeona Therapeutics reports Q3 EPS (63c) vs. (48c) last year

TIPRANKS
·
14 Nov 2024

Abeona Therapeutics expects cash to fund operations into 2026

TIPRANKS
·
14 Nov 2024

Abeona Therapeutics Q3 2024 GAAP EPS $(0.63) Misses $(0.40) Estimate

Benzinga
·
14 Nov 2024

Abeona Therapeutics Inc: Current Cash and Cash Equivalents, Credit Facility Are Sufficient Resources to Fund Ops Into 2026

THOMSON REUTERS
·
14 Nov 2024

Abeona Therapeutics Q3 Cash & Investments USD 110 Million

THOMSON REUTERS
·
14 Nov 2024